Verastem Oncology
VSTM
#7389
Rank
โ‚น40.53 B
Marketcap
โ‚น538.21
Share price
-0.17%
Change (1 day)
11.87%
Change (1 year)

Market capitalization of Verastem Oncology (VSTM)

Market cap: โ‚น40.53 Billion

As of February 2026 Verastem Oncology has a market cap of โ‚น40.53 Billion. This makes Verastem Oncology the world's 7389th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Verastem Oncology from 2012 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚น40.53 B-25.61%
2025โ‚น54.49 B284.73%
2024โ‚น14.16 B-17.27%
2023โ‚น17.12 B144.7%
2022โ‚น6.99 B-74.83%
2021โ‚น27.79 B5.11%
2020โ‚น26.44 B245.45%
2019โ‚น7.65 B-55.85%
2018โ‚น17.33 B75.04%
2017โ‚น9.90 B251.86%
2016โ‚น2.81 B-38.34%
2015โ‚น4.56 B-71.08%
2014โ‚น15.79 B-11.48%
2013โ‚น17.83 B82.01%
2012โ‚น9.80 B

End of Day market cap according to different sources

On Feb 22nd, 2026 the market cap of Verastem Oncology was reported to be:

โ‚น35.93 Billion
by Nasdaq info icon info icon
โ‚น40.53 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
โ‚น13.752 T 33,824.85%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
โ‚น2.131 T 5,159.17%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚น10.839 T 26,640.47%๐Ÿ‡ฌ๐Ÿ‡ง UK
Curis
CRIS
โ‚น1.37 B-96.60%๐Ÿ‡บ๐Ÿ‡ธ USA